Progestin-only contraceptive pill use among women in the United States.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Hall KS;Hall KS; Trussell J; Schwarz EB
  • Source:
    Contraception [Contraception] 2012 Dec; Vol. 86 (6), pp. 653-8. Date of Electronic Publication: 2012 Jun 06.
  • Publication Type:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Elsevier Country of Publication: United States NLM ID: 0234361 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0518 (Electronic) Linking ISSN: 00107824 NLM ISO Abbreviation: Contraception Subsets: MEDLINE
    • Publication Information:
      Publication: New York : Elsevier
      Original Publication: Los Altos, Calif., Geron-X.
    • Subject Terms:
      Contraception Behavior*; Contraceptives, Oral, Hormonal/*administration & dosage ; Progesterone Congeners/*administration & dosage; Adolescent ; Adult ; Breast Feeding ; Contraceptives, Oral, Hormonal/adverse effects ; Contraceptives, Oral, Synthetic/administration & dosage ; Contraceptives, Oral, Synthetic/adverse effects ; Cross-Sectional Studies ; Family Characteristics ; Female ; Health Surveys ; Humans ; Norethindrone/administration & dosage ; Norethindrone/adverse effects ; Parity ; Postpartum Period ; Pregnancy ; Progesterone Congeners/adverse effects ; Risk Factors ; United States/epidemiology ; Venous Thromboembolism/epidemiology ; Venous Thromboembolism/prevention & control ; Young Adult
    • Abstract:
      Background: Progestin-only contraceptive pills (POPs) offer a safe and effective contraceptive option, particularly for women at increased risk of venous thromboembolism. However, the prevalence of POP use among women in the United States is unknown.
      Study Design: We analyzed population-based data from 12,279 women aged 15-44 years in the National Survey of Family Growth. Data were collected continuously from 2006 to 2010 by in-person, computerized household interviews. Analyses describe POP use across sociodemographic and reproductive characteristics and thromboembolic risk profiles.
      Results: Overall, 0.4% of all reproductive-aged women in the United States currently use POPs. POP use was higher among parous, postpartum and breastfeeding women than their counterparts (all p values<.001). Women at higher risk of thromboembolism (older, obese, diabetic or smoking women) had similar proportions of POP use as women without those risks.
      Conclusion: POPs are rarely used by US women. While data on chronic disease were limited, our results suggest that relatively few women with increased risk of thromboembolism are considering POPs when choosing an oral contraceptive.
      (Copyright © 2012 Elsevier Inc. All rights reserved.)
    • References:
      Acta Obstet Gynecol Scand. 2012 Jul;91(7):810-5. (PMID: 22486520)
      Vital Health Stat 23. 2010 Aug;(29):1-44. (PMID: 20939159)
      Prev Chronic Dis. 2012;9:E34. (PMID: 22239749)
      Am J Clin Nutr. 2005 Oct;82(4):733-9. (PMID: 16210700)
      Contraception. 1982 Mar;25(3):243-52. (PMID: 6804162)
      MMWR Morb Mortal Wkly Rep. 2009 Jul 17;58(27):740-4. (PMID: 19609247)
      JAMA. 2006 Apr 5;295(13):1549-55. (PMID: 16595758)
      Contraception. 1998 May;57(5):291-301. (PMID: 9673836)
      Womens Health (Lond). 2010 Sep;6(5):721-35. (PMID: 21080791)
      Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007541. (PMID: 20091638)
      Contraception. 1995 Dec;52(6):363-9. (PMID: 8749600)
      Obstet Gynecol. 2006 Jun;107(6):1453-72. (PMID: 16738183)
      Vital Health Stat 2. 2010 Jun;(150):1-36. (PMID: 20928970)
      MMWR Morb Mortal Wkly Rep. 2011 Jul 8;60(26):878-83. (PMID: 21734635)
      Womens Health Issues. 2009 Nov-Dec;19(6):381-9. (PMID: 19879452)
      BMJ. 2009 Aug 13;339:b2890. (PMID: 19679613)
      Contraception. 2009 Dec;80(6):583-90. (PMID: 19913155)
      Arch Intern Med. 2004 Oct 11;164(18):1965-76. (PMID: 15477430)
      BMJ. 2011 Oct 25;343:d6423. (PMID: 22027398)
      Womens Health Issues. 2005 Jul-Aug;15(4):167-73. (PMID: 16051107)
    • Grant Information:
      R24 HD047879 United States HD NICHD NIH HHS; R24HD047879 United States HD NICHD NIH HHS
    • Accession Number:
      0 (Contraceptives, Oral, Hormonal)
      0 (Contraceptives, Oral, Synthetic)
      0 (Progesterone Congeners)
      T18F433X4S (Norethindrone)
    • Publication Date:
      Date Created: 20120612 Date Completed: 20130422 Latest Revision: 20211021
    • Publication Date:
      20250114
    • Accession Number:
      PMC3440515
    • Accession Number:
      10.1016/j.contraception.2012.05.003
    • Accession Number:
      22682722